Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohols from Carbonyl Compounds: Reduction02:23

Alcohols from Carbonyl Compounds: Reduction

Reduction is a simple strategy to convert a carbonyl group to a hydroxyl group. The three major pathways to reduce carbonyls to alcohols are catalytic hydrogenation, hydride reduction, and borane reduction.
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Failure of LDL-C goals achievement and underuse of lipid-lowering therapies in patients at high and very high cardiovascular risk: Spanish subset from the European SANTORINI study.

Revista clinica espanola·2024
Same author

Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view.

Journal of endocrinological investigation·2024
Same author

Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study.

Journal of endocrinological investigation·2024
Same author

Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper.

ESMO open·2023
Same author

MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view.

ESMO open·2023
Same author

Putative circulating adipose tissue-derived stem cells, obesity, and metabolic syndrome features.

Journal of endocrinological investigation·2023
Same journal

Dysregulated growth hormone-insulin-like growth factor-1 axis in adults with metabolic dysfunction-associated steatotic liver disease: a meta-analysis.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same journal

Inclisiran-will it fulfill its promise?

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same journal

Incretin-based therapies and craving: a clinical signal pointing to reward reprogramming.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same journal

Joint associations of accelerometer-measured sleep duration and physical activity with cardiovascular disease and all-cause mortality: a longitudinal cohort study.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same journal

Liver fibrosis, but not steatosis, provides incremental prognostic value beyond cardiovascular-kidney-metabolic staging.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same journal

Comment on "Temporal trends in hyperlipidemia among adults with diabetes mellitus, 1999-2024: Insights from the CDC WONDER database".

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
See all related articles

Related Experiment Video

Updated: May 11, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Moderate alcohol use and health: a consensus document.

A Poli1, F Marangoni, A Avogaro

  • 1NFI (Nutrition Foundation of Italy), Viale Tunisia 38, 20124 Milan, Italy. poli@nutrition-foundation.it

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|May 7, 2013
PubMed
Summary
This summary is machine-generated.

Moderate alcohol consumption, defined as up to 30g/day for men and 15g/day for women, is acceptable for healthy adults. However, individuals with specific health risks should consult a physician regarding their alcohol intake.

More Related Videos

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
08:37

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer

Published on: November 15, 2024

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

Related Experiment Videos

Last Updated: May 11, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
08:37

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer

Published on: November 15, 2024

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

Area of Science:

  • Public Health
  • Nutrition Science
  • Preventive Medicine

Background:

  • Understanding the complex relationship between alcohol consumption, health outcomes, and disease prevalence is crucial for public health guidance.
  • Existing evidence on moderate alcohol use requires synthesis to inform healthcare professionals and the scientific community.
  • Establishing clear guidelines for acceptable alcohol consumption levels is essential for preventive healthcare strategies.

Purpose of the Study:

  • To review and synthesize available scientific evidence on the association between moderate alcohol consumption, overall health, and the risk of various diseases.
  • To provide a comprehensive working document for scientific and healthcare professionals regarding moderate alcohol intake.
  • To offer evidence-based recommendations on alcohol consumption patterns and their health implications.

Main Methods:

  • Systematic review of existing scientific literature and epidemiological data.
  • Consensus-building among experts in public health, medicine, and nutrition.
  • Analysis of evidence linking alcohol consumption levels to specific health conditions and risk factors.

Main Results:

  • For healthy adults and the elderly, consuming up to 30 grams of ethanol daily for men and 15 grams for women is considered acceptable and generally does not warrant medical intervention.
  • Individuals with increased risk for conditions like breast cancer or cardiovascular disease, or those with existing cardiovascular issues, should discuss their drinking habits with a healthcare provider.
  • Abstainers should not be encouraged to drink alcohol for health benefits. Alcohol consumption should be discouraged in children, adolescents, pregnant or lactating women, and recovering alcoholics, as well as in conjunction with certain medications.

Conclusions:

  • The decision to consume alcohol should be individualized, considering personal health, diet, potential risks of alcoholism and abuse, and behavioral effects.
  • Promoting moderation in alcohol consumption and fostering a culture of responsible drinking alongside a healthy lifestyle is recommended.
  • Healthcare professionals should engage in discussions with patients about alcohol use, especially concerning specific risk factors and potential drug interactions.